Susquehanna Fundamental Investments, LLC Amgen Inc Transaction History

Susquehanna Fundamental Investments, LLC

$6.8 Billion
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$268.87 - $324.56 $2.8 Million - $3.38 Million	10,400 New	10,400 $2.96 Billion
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $5.78 Million - $7.18 Million	-26,447 Reduced 79.66%	6,751 $1.81 Million
Q1 2023 May 16, 2023	SELL	$225.79 - $275.2 $11.8 Million - $14.4 Million	-52,302 Reduced 61.17%	33,198 $8.03 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $7.45 Million - $8.4 Million	33,198 Added 63.47%	85,500 $19.3 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $11.5 Million - $12.7 Million	52,302 New	52,302 $12.6 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $7.43 Million - $8.5 Million	-37,347 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $2.61 Million - $3.06 Million	12,299 Added 49.1%	37,347 $7.94 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $5.14 Million - $5.7 Million	21,998 Added 721.25%	25,048 $6.11 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $7.16 Million - $8.34 Million	-32,260 Reduced 91.36%	3,050 $759,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $5.43 Million - $6.47 Million	25,110 Added 246.18%	35,310 $8.12 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $46,930 - $52,190	-200 Reduced 1.92%	10,200 $2.59 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $2.2 Million - $2.69 Million	-11,100 Reduced 51.63%	10,400 $2.45 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $346,256 - $459,230	1,900 Added 9.69%	21,500 $4.36 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $2.54 Million - $3.26 Million	13,400 Added 216.13%	19,600 $4.73 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $34,822 - $41,724	200 Added 3.33%	6,200 $1.2 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $266,720 - $312,656	1,600 Added 36.36%	6,000 $1.11 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $2.95 Million - $3.33 Million	-16,319 Reduced 78.76%	4,400 $836,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $36,215 - $42,274	203 Added 0.99%	20,719 $4.03 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $2.21 Million - $2.49 Million	11,916 Added 138.56%	20,516 $4.25 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $1.01 Million - $1.13 Million	-6,060 Reduced 41.34%	8,600 $1.59 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $2.48 Million - $2.9 Million	14,660 New	14,660 $2.5 Million

Others Institutions Holding AMGN

# of Institutions

3,173

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

Vanguard Group Inc Valley Forge, PA

52.7M
Shares

$16.4 Billion
0.25% of portfolio
Black Rock Inc. New York, NY

46M
Shares

$14.3 Billion
0.33% of portfolio
State Street Corp Boston, MA

29.4M
Shares

$9.15 Billion
0.31% of portfolio
Morgan Stanley New York, NY

14.6M
Shares

$4.52 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

13.2M
Shares

$4.1 Billion
0.65% of portfolio

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.

Account